|
|
|
Insider
Information: |
Henneman John B III |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
285,781 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,082,115 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
285,781 |
|
|
Total
Value |
$4,082,115 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-30.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-06-20 |
9,184 |
2019-10-07 |
0 |
Premium* |
|
Anika Therapeutics Inc |
ANIK |
Director |
2024-07-09 |
35,707 |
2020-09-03 |
0 |
Premium* |
|
R1 Rcm Inc |
RCM |
Director |
2024-05-23 |
87,765 |
2022-06-21 |
0 |
Premium* |
|
Orthofix International N.V. |
OFIX |
|
2024-06-18 |
63,914 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
171 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OFIX |
Orthofix International N.... |
Director |
|
2023-01-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,408 |
|
% |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2009-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
132,078 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2009-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,813 |
94,441 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2009-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
92,641 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2010-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,366 |
93,901 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2010-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
62,710 |
147,134 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2011-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,855 |
121,922 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2011-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
38,507 |
72,149 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
EVP, Finance & Admin & CFO |
|
2012-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
6,380 |
74,674 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
CorpVP,Finan&Admn,CFO,Asst.Sec |
|
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
25,388 |
89,930 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
CorpVP,Finan&Admn,CFO,Asst.Sec |
|
2013-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,739 |
102,669 |
0 |
- |
|
IART |
Integra Lifesciences Hold... |
CorpVP, Finance & Admin, CFO |
|
2014-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
16,107 |
69,718 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2014-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,789 |
40,789 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
47,789 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2015-02-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
47,489 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
|
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
16,201 |
62,491 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2016-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,010 |
18,903 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,121 |
34,024 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,286 |
47,310 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
61,970 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,488 |
70,458 |
0 |
- |
|
ANIK |
Anika Therapeutics Inc |
Director |
|
2020-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,310 |
9,310 |
0 |
- |
|
SPNE |
Seaspine Holdings Corp |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,253 |
66,711 |
0 |
- |
|
ANIK |
Anika Therapeutics Inc |
Director |
|
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,172 |
15,482 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
Director |
|
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,610 |
9,610 |
0 |
- |
|
171 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|